What we deliver
We turn metabolic-disease biology into decisions — mechanism-to-market strategy, biomarker and endpoint planning, competitive positioning, and scientific narrative, grounded in graded evidence, not hype.
A focused set of advisory services, each scoped to the specific scientific and strategic decision at hand. Engagements are founder-led, defined in writing, confidential, and built around a clear deliverable.
Strategic Scientific Memo
Hypothesis-driven analysis for board, investor, or internal decision-making. The central deliverable distills the question, the evidence, the options, and a clear, defensible recommendation — supported by the specialized services below when the scope calls for them.
01Mechanism-to-market strategy
For founders and platform teams turning strong biology into a path forward. Deliverable: a strategic memo linking mechanism to indication, evidence, and positioning.
02Metabolic landscape & Strategy Reports
For teams entering or repositioning in metabolic disease. Deliverable: an evidence-graded read of the field — a curated or published Strategy Report.
03Asset differentiation assessment
For BD, investors, and founders asking how an asset truly differs from the leaders and the pipeline. Deliverable: a differentiation and defensibility map.
04Biomarker & endpoint strategy
For clinical-development and translational teams. Deliverable: an endpoint and biomarker rationale that holds up under diligence and review.
05Clinical-trial evidence mapping
For investors and development teams. Deliverable: the trial and approval landscape, graded by evidence stage (approved / trial / emerging).
06White-space analysis
For founders and strategy teams seeking defensible ground. Deliverable: a scientific and strategic white-space and risk map.
07Scientific narrative development
For teams raising capital who need a story that survives scrutiny. Deliverable: refined narrative and technical positioning for decks and materials.
08Founder / CEO scientific positioning
For founder-CEOs representing their science to investors and partners. Deliverable: a positioning brief with messaging guardrails.
09Diligence support
For investors and BD wanting an independent read before committing. Deliverable: a diligence memo on mechanism, evidence, and risk — independent, and not a recommendation to transact.
10Advisory bench support
When a question needs adjacent expertise — neuroscience, cancer biology, behavioral health, legal/commercial, or translational program design — a focused advisory bench contributes within a scoped engagement.
Each engagement begins with a written scope defining the question, sources, assumptions, timeline, confidentiality, and output. Services can be combined into a single deliverable or sequenced across a longer relationship.
Have a scientific strategy question?
For confidential biotech, spinout, investor, or strategic diligence inquiries, start with a brief scoping conversation.
Request a confidential scoping callPrefer email? contact@valdezbiostrategy.com